Hemoperfusion and liver disease

G. Visco, R. Giannuzzi, M. G. Paglia, U. V. Comandini

Research output: Contribution to journalArticlepeer-review

Abstract

After first adventurous attempts to apply perfusion techniques to the treatment of liver diseases, more extensive experiences have been acquired in the last twenty years, not only in acute hepatic failure but also in some chronic liver diseases (mainly in CAH: chronic active hepatitis, and in primary biliary cirrhosis) and in a severe complication of them, that is cryoglobulinemia. Some experiences on this field that are found in literature, using both plasma exchange and hemoperfusion, are reviewed and some personal data are reported: 15 patients with acute viral liver failure (survival rate: 33%) and 5 patients with a CAH-linked (3 viral and 2 autoimmune) cryoglobulinaemia, in whom a good control of the disease parameters was obtained.

Original languageEnglish
Pages (from-to)265-281
Number of pages17
JournalBiomaterials, Artificial Cells, and Immobilization Biotechnology
Volume21
Issue number2
Publication statusPublished - 1993

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Hemoperfusion and liver disease'. Together they form a unique fingerprint.

Cite this